{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,19]],"date-time":"2026-06-19T22:05:46Z","timestamp":1781906746563,"version":"3.54.5"},"reference-count":42,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2023,4,1]],"date-time":"2023-04-01T00:00:00Z","timestamp":1680307200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,4,1]],"date-time":"2023-04-01T00:00:00Z","timestamp":1680307200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["brainanddevelopment.com","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Brain and Development"],"published-print":{"date-parts":[[2023,4]]},"DOI":"10.1016\/j.braindev.2022.11.006","type":"journal-article","created":{"date-parts":[[2022,12,13]],"date-time":"2022-12-13T15:27:08Z","timestamp":1670945228000},"page":"212-219","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"title":["Sialic acid and anti-ganglioside M1 antibodies are invaluable biomarkers correlated with the severity of autism spectrum disorder"],"prefix":"10.1016","volume":"45","author":[{"given":"Engy A.","family":"Ashaat","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sahar","family":"Sabry","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Moushira E.","family":"Zaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ramy","family":"Mohamed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hoda A.","family":"Abdelsattar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Somia A.","family":"Bawady","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Neveen A.","family":"Ashaat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Walaa","family":"Elnaggar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mona M.F.","family":"Ganem","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hazem M.","family":"El-Hariri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hala T.","family":"El-Bassyouni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dina Amin","family":"Saleh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.braindev.2022.11.006_b0005","series-title":"Diagnostic and Statistical Manual of Mental Disorders: DSM-5","article-title":"DSM-5 Task Force","author":"American Psychiatric Association","year":"2013"},{"key":"10.1016\/j.braindev.2022.11.006_b0010","unstructured":"Centers for Disease Control and Prevention. Data & Statistics on Autism Spectrum Disorder. 2018. Available online: https:\/\/www.cdc.gov\/ncbddd\/autism\/data.html (accessed on 2 March 2022)."},{"issue":"4","key":"10.1016\/j.braindev.2022.11.006_b0015","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1038\/mp.2011.165","article-title":"A review of research trends in physiological abnormalities in autism spectrum disorders: immune dysregulation, inflammation, oxidative stress, mitochondrial dysfunction and environmental toxicant exposures","volume":"17","author":"Rossignol","year":"2011","journal-title":"Molecul Psych"},{"issue":"1\u20132","key":"10.1016\/j.braindev.2022.11.006_b0020","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1016\/S0165-5728(02)00180-7","article-title":"Antibodies to neuron-specific antigens in children with autism: possible cross-reaction with encephalitogenic proteins from milk, Chlamydia pneumoniae and Streptococcus group A","volume":"129","author":"Vojdani","year":"2002","journal-title":"J Neuroimmunol"},{"key":"10.1016\/j.braindev.2022.11.006_b0025","first-page":"21","article-title":"Antineuronal antibodies in autistic children: relation to blood mercury","volume":"5","author":"Mostafa","year":"2007","journal-title":"Egypt J Pediatr Allergy Immunol"},{"key":"10.1016\/j.braindev.2022.11.006_b0030","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1016\/j.mam.2016.07.001","article-title":"Glycan susceptibility factors in autism spectrum disorders","volume":"51","author":"Dwyer","year":"2016","journal-title":"Mol Aspects Med"},{"issue":"3","key":"10.1016\/j.braindev.2022.11.006_b0035","doi-asserted-by":"crossref","first-page":"465S","DOI":"10.3945\/an.112.001875","article-title":"Molecular mechanism underlying sialic acid as an essential nutrient for brain development and cognition","volume":"3","author":"Wang","year":"2012","journal-title":"Adv Nutr"},{"issue":"2","key":"10.1016\/j.braindev.2022.11.006_b0040","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1152\/physrev.00033.2013","article-title":"Sialic Acids in the Brain: Gangliosides and Polysialic Acid in Nervous System Development, Stability, Disease, and Regeneration","volume":"94","author":"Schnaar","year":"2014","journal-title":"Physiol Rev"},{"key":"10.1016\/j.braindev.2022.11.006_b0045","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1007\/978-1-4939-8552-4_2","article-title":"Gangliosides of the Nervous System","volume":"1804","author":"Ledeen","year":"2018","journal-title":"Methods Mol Biol"},{"issue":"3","key":"10.1016\/j.braindev.2022.11.006_b0050","doi-asserted-by":"crossref","first-page":"868","DOI":"10.3390\/ijms21030868","article-title":"GM1 Ganglioside is a key factor in maintaining the mammalian neuronal functions avoiding neurodegeneration","volume":"21","author":"Chiricozzi","year":"2020","journal-title":"Int J Mol Sci"},{"issue":"8","key":"10.1016\/j.braindev.2022.11.006_b0055","doi-asserted-by":"crossref","first-page":"1739","DOI":"10.1016\/j.bbagen.2016.04.015","article-title":"Relationship between ST8SIA2, polysialic acid and its binding molecules, and psychiatric disorders","volume":"1860","author":"Sato","year":"2016","journal-title":"Biochim Biophys Acta"},{"issue":"8","key":"10.1016\/j.braindev.2022.11.006_b0060","doi-asserted-by":"crossref","first-page":"958","DOI":"10.1111\/j.1601-183X.2010.00635.x","article-title":"Differential impact of polysialyltransferase ST8SiaII and ST8SiaIV knockout on social interaction and aggression","volume":"9","author":"Calandreau","year":"2010","journal-title":"Genes Brain Behav"},{"issue":"4","key":"10.1016\/j.braindev.2022.11.006_b0065","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1016\/j.neuroscience.2008.08.034","article-title":"Neuromuscular synaptic function in mice lacking major subsets of gangliosides","volume":"156","author":"Zitman","year":"2008","journal-title":"Neuroscience"},{"issue":"4","key":"10.1016\/j.braindev.2022.11.006_b0070","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1038\/s41423-020-0388-9","article-title":"Physiology of gangliosides and the role of antiganglioside antibodies in human diseases","volume":"17","author":"Cutillo","year":"2020","journal-title":"Cell Mol Immunol"},{"issue":"6","key":"10.1016\/j.braindev.2022.11.006_b0075","first-page":"1065","article-title":"Pathomechanism of autoantibody production in neurological disorders","volume":"66","author":"Watanabe","year":"2008","journal-title":"Nihon Rinsho"},{"issue":"12","key":"10.1016\/j.braindev.2022.11.006_b0080","doi-asserted-by":"crossref","first-page":"1413","DOI":"10.1177\/0883073808319321","article-title":"Serum Anti-Myelin-Associated Glycoprotein Antibodies in Egyptian Autistic Children","volume":"23","author":"Mostafa","year":"2008","journal-title":"J Child Neurol"},{"issue":"8","key":"10.1016\/j.braindev.2022.11.006_b0085","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1186\/1742-2094-8-39","article-title":"Increased serum levels of anti-ganglioside M1 auto-antibodies in autistic children: relation to the disease severity","volume":"25","author":"Mostafa","year":"2011","journal-title":"J Neuroinflam"},{"issue":"6","key":"10.1016\/j.braindev.2022.11.006_b0090","doi-asserted-by":"crossref","first-page":"1201","DOI":"10.1007\/s11064-011-0697-6","article-title":"Cholesterol, GM1, and Autism","volume":"37","author":"Schengrund","year":"2012","journal-title":"Neurochem Res"},{"issue":"5","key":"10.1016\/j.braindev.2022.11.006_b0095","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1177\/0734282911400873","article-title":"Test Review: E. Schopler, ME Van Bourgondien, GJ Wellman, & SR. Love Childhood Autism Rating Scale (2nd ed.). Los Angeles, CA: Western Psychological Services, 2010","volume":"29","author":"Vaughan","year":"2011","journal-title":"J Pshychoeduc Assess"},{"key":"10.1016\/j.braindev.2022.11.006_b0100","series-title":"Crecere nel mondo","article-title":"Egyptian growth curves for infants, children and adolescents","author":"Ghalli","year":"2002"},{"issue":"1","key":"10.1016\/j.braindev.2022.11.006_b0105","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1186\/s12944-019-1113-5","article-title":"Sialic acid metabolism as a potential therapeutic target of atherosclerosis","volume":"18","author":"Zhang","year":"2019","journal-title":"Lipids Health Dis"},{"issue":"1\u20132","key":"10.1016\/j.braindev.2022.11.006_b0110","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/0009-8981(93)90204-H","article-title":"Serum sialic acid and acute phase proteins in type 1 and type 2 diabetes mellitus","volume":"219","author":"Crook","year":"1993","journal-title":"Clin Chim Acta"},{"issue":"5","key":"10.1016\/j.braindev.2022.11.006_b0115","doi-asserted-by":"crossref","first-page":"471","DOI":"10.3109\/00365518509155245","article-title":"An enzyme linked immunosorbent assay (ELISA) for measurement of human serum thyroglobulin. Evaluation of the influence of thyroglobulin auto-antibodies","volume":"45","author":"Kastrup","year":"1985","journal-title":"Scand J Clin Lab Invest"},{"issue":"3","key":"10.1016\/j.braindev.2022.11.006_b0120","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1002\/mrdd.10081","article-title":"A systems neuroscience approach to autism: Biological, cognitive, and clinical perspectives","volume":"9","author":"Eigsti","year":"2003","journal-title":"Ment Retard Dev Disabil Res Rev"},{"issue":"17","key":"10.1016\/j.braindev.2022.11.006_b0125","doi-asserted-by":"crossref","first-page":"1770","DOI":"10.1001\/jama.2014.4144","article-title":"The Familial Risk of Autism","volume":"311","author":"Sandin","year":"2014","journal-title":"JAMA"},{"issue":"1","key":"10.1016\/j.braindev.2022.11.006_b0130","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1177\/0883073807307102","article-title":"Autism Spectrum Disorders: Concurrent Clinical Disorders","volume":"23","author":"Ming","year":"2007","journal-title":"J Child Neurol"},{"issue":"3","key":"10.1016\/j.braindev.2022.11.006_b0135","doi-asserted-by":"crossref","first-page":"15","DOI":"10.5409\/wjcp.v10.i3.15","article-title":"Autism medical comorbidities","volume":"10","author":"Al-Beltagi","year":"2021","journal-title":"World J Clin Pediatr"},{"issue":"2","key":"10.1016\/j.braindev.2022.11.006_b0140","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1023\/A:1023036509476","article-title":"Microcephaly and macrocephaly in autism","volume":"29","author":"Fombonne","year":"1999","journal-title":"J Autism Dev Disord"},{"issue":"2","key":"10.1016\/j.braindev.2022.11.006_b0145","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1016\/j.pscychresns.2015.08.016","article-title":"Head circumference and brain size in autism spectrum disorder: A systematic review and meta-analysis","volume":"234","author":"Sacco","year":"2015","journal-title":"Psychiatry Res"},{"issue":"3","key":"10.1016\/j.braindev.2022.11.006_b0150","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1177\/08830738050200030601","article-title":"Screening Electroencephalograms in Autism Spectrum Disorders: Evidence-Based Guideline","volume":"20","author":"Kagan-Kushnir","year":"2005","journal-title":"J Child Neurol"},{"issue":"2","key":"10.1016\/j.braindev.2022.11.006_b0155","doi-asserted-by":"crossref","first-page":"59","DOI":"10.4103\/1110-1105.209676","article-title":"EEG abnormalities and severity of symptoms in non-epileptic autistic children","volume":"38","author":"Youssef","year":"2017","journal-title":"Egypt J Psychiatr"},{"key":"10.1016\/j.braindev.2022.11.006_b0160","doi-asserted-by":"crossref","first-page":"46041","DOI":"10.1038\/srep46041","article-title":"Serum glycopattern and Maackia amurensis lectin-II binding glycoproteins in autism spectrum disorder","volume":"7","author":"Qin","year":"2017","journal-title":"Sci Rep"},{"key":"10.1016\/j.braindev.2022.11.006_b0165","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1016\/j.brainres.2017.10.027","article-title":"Sialic acid and anti-ganglioside antibody levels in children with autism spectrum disorders","volume":"1678","author":"Yang","year":"2018","journal-title":"Brain Res"},{"issue":"3","key":"10.1016\/j.braindev.2022.11.006_b0170","doi-asserted-by":"crossref","first-page":"415","DOI":"10.9758\/cpn.2019.17.3.415","article-title":"Levels of Salivary Sialic Acid in Children with Autism Spectrum Disorder; Could It Be Related to Stereotypes and Hyperactivity?","volume":"17","author":"Demirci","year":"2019","journal-title":"Clin Psychopharmacol Neurosci"},{"key":"10.1016\/j.braindev.2022.11.006_b0175","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1186\/s43045-022-00202-3","article-title":"Anti-ganglioside M1 autoantibodies in Egyptian children with autism: a cross-sectional comparative study","volume":"29","author":"Hamed","year":"2022","journal-title":"Middle East Curr Psychiatry"},{"issue":"5","key":"10.1016\/j.braindev.2022.11.006_b0180","doi-asserted-by":"crossref","first-page":"926","DOI":"10.1111\/j.1471-4159.2010.07067.x","article-title":"Gangliosides are essential in the protection of inflammation and neurodegeneration via maintenance of lipid rafts: elucidation by a series of ganglioside-deficient mutant mice","volume":"116","author":"Ohmi","year":"2011","journal-title":"J Neurochem"},{"issue":"1\u20132","key":"10.1016\/j.braindev.2022.11.006_b0185","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/0166-4328(94)00131-X","article-title":"Brain gangliosides and memory formation","volume":"66","author":"Rahmann","year":"1995","journal-title":"Behav Brain Res"},{"issue":"5","key":"10.1016\/j.braindev.2022.11.006_b0190","doi-asserted-by":"crossref","first-page":"3891","DOI":"10.3390\/nu7053891","article-title":"The Role of Gangliosides in Neurodevelopment","volume":"7","author":"Palmano","year":"2015","journal-title":"Nutrients"},{"issue":"1\u20132","key":"10.1016\/j.braindev.2022.11.006_b0195","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/j.jneuroim.2007.11.004","article-title":"Antibodies against fetal brain in sera of mothers with autistic children","volume":"194","author":"Singer","year":"2008","journal-title":"J Neuroimmunol"},{"key":"10.1016\/j.braindev.2022.11.006_b0200","unstructured":"Nordin V, Lekman A, Johansson M, Fredman P, Gillberg C. Gangliosides in cerebrospinal fluid in children with autism spectrum disorders. Dev Med Child Neurol."},{"key":"10.1016\/j.braindev.2022.11.006_b0205","doi-asserted-by":"crossref","DOI":"10.1016\/j.jns.2019.116576","article-title":"Antiganglioside antibodies in neurological diseases","volume":"408","author":"Wanleenuwat","year":"2020","journal-title":"J Neurol Sci"},{"key":"10.1016\/j.braindev.2022.11.006_b0210","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1007\/978-1-4684-7844-0_2","article-title":"Ganglioside Designation","volume":"125","author":"Svennerholm","year":"1980","journal-title":"Adv Exp Med Biol"}],"container-title":["Brain and Development"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0387760422002066?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0387760422002066?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,8]],"date-time":"2025-10-08T19:51:31Z","timestamp":1759953091000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0387760422002066"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,4]]},"references-count":42,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2023,4]]}},"alternative-id":["S0387760422002066"],"URL":"https:\/\/doi.org\/10.1016\/j.braindev.2022.11.006","relation":{},"ISSN":["0387-7604"],"issn-type":[{"value":"0387-7604","type":"print"}],"subject":[],"published":{"date-parts":[[2023,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Sialic acid and anti-ganglioside M1 antibodies are invaluable biomarkers correlated with the severity of autism spectrum disorder","name":"articletitle","label":"Article Title"},{"value":"Brain and Development","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.braindev.2022.11.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Published by Elsevier B.V. on behalf of The Japanese Society of Child Neurology. All rights reserved.","name":"copyright","label":"Copyright"}]}}